Researchers from BC Cancer and the University of British Columbia (UBC) have discovered that certain bacteria found in breast tumours could be linked to metastasis, or the spread of cancer to other parts of the body. The findings, published in mBio, a journal of the American Society of Microbiology, suggest that Bacillus bacteria in the tumour micro-environment can play an active role in metastasis.
A new study co-authored by Dr. Rafael Meza, scientist with BC Cancer, reveals the significant live-saving potential of policies that raise the minimum legal age for purchasing tobacco products.
Congratulations to the recipients of the BC Cancer Foundation (BCCF) 2024 Rising Stars Award competition!
This year’s awardees are:
BC Cancer researchers receive Cancer Research Society’s Doctoral Research Awards
Three BC Cancer graduate students are 2024 recipients of Doctoral Research Awards from the Cancer Research Society (CRS), receiving new funding to support their innovative research aimed at better understanding cancer.
Doctoral Research Awards recipients
Doctoral Research Awards invests in the future of cancer research through the support of graduate students pursuing cancer research at an eligible Canadian institution.
Dr. Katey Enfield is an Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia (UBC), and a Scientist in the Department of Integrative Oncology at the BC Cancer Research Institute (BCCRI). Dr. Enfield received her PhD from UBC under the supervision of Dr. Wan Lam, where she employed a multiomics approach to discover and characterize oncogenes and tumour suppressor genes.
As the most commonly diagnosed cancer, lung cancer accounts for a quarter of all cancer deaths — more people will die from lung cancer this year than from colorectal, pancreatic and breast cancers combined.
This is due to the fact that most patients are referred to BC Cancer once they’ve developed symptoms. As a result, nearly half of lung cancer cases are detected in Stage 4 after the cancer has metastasized. The five-year survival rate for the disease is 62% in Stage 1 but drops to just 3% in Stage 4.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.